Davis's Drug Guide
Tri-Norinyl
Phase I
norethindrone 0.5 mg + ethinyl estradiol 35 mcg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tri-Norinyl." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/61363/all/Tri_Norinyl.
Vallerand AHA, Sanoski CAC, Quiring CC. Tri-Norinyl. Davis's Drug Guide. F.A. Davis Company; 2024. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/61363/all/Tri_Norinyl. Accessed November 12, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Tri-Norinyl. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/61363/all/Tri_Norinyl
Vallerand AHA, Sanoski CAC, Quiring CC. Tri-Norinyl [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 12]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/61363/all/Tri_Norinyl.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tri-Norinyl
ID - 61363
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/61363/all/Tri_Norinyl
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
